Are you struggling with treatment-resistant bipolar depression? Stanford University’s Brain Stimulation Lab (BSL) is offering a unique opportunity to participate in a groundbreaking research study aimed at bringing relief to individuals like you.
The study, titled “Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-resistant Bipolar Depression,” explores the potential of a novel therapy called Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT), also known as Stanford Neuromodulation Therapy (SNT). This innovative approach uses magnetic pulses to target specific brain regions involved in mood regulation, offering hope for those who haven’t found success with traditional antidepressants.
What is SNT and why is it exciting?
SNT builds upon a form of brain stimulation called intermittent theta-burst stimulation (iTBS). Stanford BSL researchers have refined this technique, delivering it in a more rapid and personalized manner. Early results from a double-blinded clinical trial have shown remarkable success in treating unipolar depression, with remission rates ranging from 50% to 90%.
Please refer to the flyers below for more details:
Related Content
